A recent study links tablet-toting reps with a greater prescribing impact, while other data suggest direct marketing tops all other forms of promotional outreach.
An AstraZeneca-sponsored study found that doctors who don’t see sales reps are far slower to respond to medical developments such as new products, black box warnings and clinical trials data.
Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn’t shared evenly between the biggest of pharmas, as a number of players scaled up.
Siding with Lilly, appeals court overturns decision in rep overtime case
The latest round of Sales Reps vs. Pharma has favored…the pharma industry. The Seventh Circuit Court of Appeals said that Eli Lilly did not owe former rep Susan Schaeffer-LaRose overtime.